{"tid":600809,"cid":15,"subCid":0,"title":"【EJFQ短評】中國生物製藥以大成交向上破頂 料升勢未止","createTime":"2018-03-21T15:52:07.000Z","updateTime":"2018-03-21T15:52:07.000Z","uid":70274,"like":0,"dislike":1,"uniUserReply":1,"replies":[{"pid":"5f52387b8f1d1a71bfec4f7327f41384c9ff2436","tid":600809,"uid":70274,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2018-03-21T15:52:07.000Z","msg":"即巿股評 港股直擊 <br />\n Image description<br />\n中國生物製藥(01177)企穩10天、20天及50天線後以大成交向上破頂，EJFQ勢頭能量強勁，表現跑贏恒指，料升勢未止；EJFQ於2016年10月7日發出長線綠燈，至今升186.2%。<br />\n<br />\n信報投資研究部"}]}